Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...

Experts call the health implications “dire” with some fearing Kennedy could set off a fresh round in the school culture wars ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

Thousands of treated patients support the potential of phage therapy, but limited knowledge of this technique and its ...

Evaluate, the leading provider of market insights for the pharmaceutical industry, today released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.

Ad hoc announcement pursuant to Art. 53 LR Presentation to take place on January 15, 2025, at 15:00 PST / 00:00 CET and will be available for replay on demand Allschwil, Switzerland - January 15 ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

Inherited eye disorders such as retinitis pigmentosa (RP) leave millions grappling with progressive vision loss. At the heart ...

Future Directions Further studies are needed to explore the mechanisms linking pulmonary disease to kidney ... Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate ...

Update on evaluation of cystic fibrosis transmembrane conductance regulator modulator ... “Within the agreement between NHS England and Vertex there is a flexible commercial mechanism to ensure ...